Applications for Fellowship
The Organising Committee of the 9th Symposium of the European Academy of Dermatology and Venereology will offer 100 grants of reduced registration fee (Fellowship registration fee, EUR 100) to dermatologists (EADV members) who are not otherwise supported to attend the above mentioned Symposium.
APPLICATION DEADLINE IS NOW CLOSED!
Terms & Conditions
- Applications must be received strictly by the closing date. Any late applications will not be considered.
- Applications will be assessed by the Honours & Awards Committee and their decision will be final.
- Fellowships are only assigned to individuals and will be granted one time only
- Companies or travel agencies are not eligible for fellowships
- Please note that block bookings will receive no consideration
- Preference may be given to applicants who have submitted an abstract or poster.
- You will be notified if your application was successful by 2 April, 2012
Use of Data - Authorisation
The data made available through this form are gathered and treated by the EADV in compliance with the Swiss regulation on data protection, in particular in compliance with Sec. 4 of the Swiss Federal Law of June 19, 1992 on data protection. All data are treated by the EADV only for organisational purposes, in particular for the registration to congresses and/or symposia as well as for the monitoring of credits for the Continued Medical Education of the participants.
At any congress and symposium each participant receives one badge carrying the family name and the first name of the participants as well as bar code. Through the bar code all data on this form can be accessed through software at the sole disposal of EADV. Each participant shall consider that by accepting any scanning of any badge at any stand at the congress or symposium, the participant gives his / her authorisation to the EADV to transfer to the holder of the stand (usually a pharmaceutical company) the data of the participant regarding his / her postal address and e-mail, including the authorisation to use said data for commercial purposes such as the marketing of pharmaceutical products and similar.